Literature DB >> 2822061

Monoclonal antibody to human lung angiotensin-converting enzyme.

S M Danilov1, E A Dukhanina, I N Trakht.   

Abstract

The hybridoma producing monoclonal antibody (IgG1) to human angiotensin-converting enzyme (ACE) has been prepared by fusion of murine myeloma P3O1 with spleen cells of BALB/c mice immunized with a purified human lung ACE preparation. A high specificity of monoclonal antibody (MAb) binding to immobilized ACE has been demonstrated by enzyme-linked immunosorbent assay and that of soluble ACE by an immunoadsorption test. The latter technique permits the use of impure ACE preparations for the screening procedure. This MAb did not affect ACE activity. We believe this antibody will be useful not only for immunoassay and immunopurification of ACE, but also as a tool for the investigation of the tissue distribution of the enzyme as well as for the study of the structure and mechanism of action of ACE.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2822061

Source DB:  PubMed          Journal:  Biotechnol Appl Biochem        ISSN: 0885-4513            Impact factor:   2.431


  3 in total

1.  Immunohistochemical study of angiotensin-converting enzyme in human tissues using monoclonal antibodies.

Authors:  S M Danilov; A I Faerman; A V Martynov; I N Trakht
Journal:  Histochemistry       Date:  1987

2.  Systemic administration of platelet-activating factor in rat reduces specific pulmonary uptake of circulating monoclonal antibody to angiotensin-converting enzyme.

Authors:  E N Atochina; H H Hiemisch; V R Muzykantov; S M Danilov
Journal:  Lung       Date:  1992       Impact factor: 2.584

3.  Conformational fingerprint of blood and tissue ACEs: Personalized approach.

Authors:  Sergei M Danilov; Victoria E Tikhomirova; Olga V Kryukova; Alexander V Balatsky; Naida I Bulaeva; Elena Z Golukhova; Leo A Bokeria; Larisa M Samokhodskaya; Olga A Kost
Journal:  PLoS One       Date:  2018-12-27       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.